What You Need to Know at This Stage of the Coronavirus Vaccine Race
As of now, 10 programs are involved in phase 3 studies. The Vaccines and Related Biological Products Advisory Committee will meet Oct. 22 to discuss studies that should be performed to further confirm vaccine candidates' safety and efficacy (whether pre- or post-approval). In a briefing document, the FDA emphasized that any emergency use authorization (EUA) must be supported by phase 3 data.